|
Name |
Fonsecinone A
|
Molecular Formula | C32H26O10 | |
IUPAC Name* |
5-hydroxy-9-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxobenzo[g]chromen-10-yl)-8,10-dimethoxy-2-methylbenzo[h]chromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(C=C3C=C(C(=C(C3=C2O1)OC)C4=C5C(=C(C6=C4C=C(C=C6OC)OC)O)C(=O)C=C(O5)C)OC)O
|
|
InChI |
InChI=1S/C32H26O10/c1-13-7-18(33)26-20(35)9-15-10-21(38-4)28(30(40-6)23(15)31(26)41-13)25-17-11-16(37-3)12-22(39-5)24(17)29(36)27-19(34)8-14(2)42-32(25)27/h7-12,35-36H,1-6H3
|
|
InChIKey |
FFNPXDMNZBCNMN-UHFFFAOYSA-N
|
|
Synonyms |
FONSECINONE A; 95152-75-3; CHEMBL451678; 4422E9639H; 4H-Naphtho(2,3-b)pyran-4-one, 5-hydroxy-10-(5-hydroxy-8,10-dimethoxy-2-methyl-4-oxo-4H-naphtho(1,2-b)pyran-9-yl)-6,8-dimethoxy-2-methyl-; 5-Hydroxy-10-(5-hydroxy-8,10-dimethoxy-2-methyl-4-oxo-4H-naphtho(1,2-b)pyran-9-yl)-6,8-dimethoxy-2-methyl-4H-naphtho(2,3-b)pyran-4-one; 5-hydroxy-9-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxobenzo[g]chromen-10-yl)-8,10-dimethoxy-2-methylbenzo[h]chromen-4-one; 5-hydroxy-10-(5-hydroxy-8,10-dimethoxy-2-methyl-4-oxo-4H-naphtho[1,2-b]pyran-9-yl)-6,8-dimethoxy-2-methyl-4H-naphtho[2,3-b]pyran-4-one; (aS)-fonsecinone A; CHEBI:133759; DTXSID101317742; UNII-4422E9639H; BDBM50241853; Q27896467; 5-hydroxy-9-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxo-benzo[g]chromen-10-yl)-8,10-dimethoxy-2-methyl-benzo[h]chromen-4-one
|
|
CAS | 95152-75-3 | |
PubChem CID | 10325700 | |
ChEMBL ID | CHEMBL451678 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 570.5 | ALogp: | 6.3 |
HBD: | 2 | HBA: | 10 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 130.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 42 | QED Weighted: | 0.187 |
Caco-2 Permeability: | -5.066 | MDCK Permeability: | 0.00002480 |
Pgp-inhibitor: | 0.931 | Pgp-substrate: | 0.083 |
Human Intestinal Absorption (HIA): | 0.422 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.402 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 63.72% |
Volume Distribution (VD): | 0.464 | Fu: | 50.17% |
CYP1A2-inhibitor: | 0.197 | CYP1A2-substrate: | 0.99 |
CYP2C19-inhibitor: | 0.448 | CYP2C19-substrate: | 0.462 |
CYP2C9-inhibitor: | 0.701 | CYP2C9-substrate: | 0.94 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.898 |
CYP3A4-inhibitor: | 0.079 | CYP3A4-substrate: | 0.266 |
Clearance (CL): | 3.375 | Half-life (T1/2): | 0.151 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.191 |
Drug-inuced Liver Injury (DILI): | 0.985 | AMES Toxicity: | 0.166 |
Rat Oral Acute Toxicity: | 0.322 | Maximum Recommended Daily Dose: | 0.915 |
Skin Sensitization: | 0.088 | Carcinogencity: | 0.018 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.333 |
Respiratory Toxicity: | 0.088 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001501 | 0.871 | D06GCK | 0.360 | ||||
ENC002093 | 0.841 | D0G4KG | 0.300 | ||||
ENC001411 | 0.832 | D02LZB | 0.282 | ||||
ENC000922 | 0.789 | D09DHY | 0.281 | ||||
ENC003154 | 0.771 | D0NJ3V | 0.272 | ||||
ENC000912 | 0.762 | D0V8HJ | 0.249 | ||||
ENC003507 | 0.735 | D0D4HN | 0.248 | ||||
ENC003048 | 0.733 | D0Y6CE | 0.245 | ||||
ENC000984 | 0.708 | D0FA2O | 0.244 | ||||
ENC003149 | 0.648 | D03RTK | 0.242 |